Brief: Infinity Pharmaceuticals Reports Q3 Earnings

Infinity Pharmaceuticals

30/10/2019 21:54

Oct 30 (Reuters) - Infinity Pharmaceuticals Inc  INFI.O :
    * Q3 LOSS PER SHARE $0.20
    * Q3 EARNINGS PER SHARE ESTIMATE $-0.10 -- REFINITIV IBES
DATA
    * -- MARIO-3 ENROLLMENT COMPLETION AND DATA PRESENTATION
EXPECTED
IN 2020
    * MARIO-275 ENROLLMENT COMPLETION EXPECTED IN 2020
    * MARIO-1 ENROLLMENT COMPLETION EXPECTED IN 2019 AND DATA
PRESENTATION EXPECTED IN 2020
    * EXPECTS NET LOSS FOR 2019 TO RANGE FROM $40 MILLION TO $50
MILLION
    * INFINITY PHARMACEUTICALS - EXPECTS TO END 2019 CASH, CASH
EQUIVALENTS AND AVAILABLE-FOR-SALE SECURITIES BALANCE RANGING
FROM $40 MILLION TO $50 MILLION
    * INFINITY PHARMACEUTICALS - EXPECTS EXISTING CASH,
EQUIVALENTS
AND  SECURITIES WILL BE ADEQUATE TO SATISFY CAPITAL NEEDS FOR AT
LEAST NEXT 12 MONTHS

Source text for Eikon:  ID:nBw5KLC93a 
Further company coverage:  INFI.O 

 ((Reuters.Briefs@thomsonreuters.com;))